Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.19
+0.01500.47%
Volume:4.64M
Turnover:14.83M
Market Cap:1.68B
PE:-2.21
High:3.26
Open:3.10
Low:3.10
Close:3.17
52wk High:7.18
52wk Low:2.98
Shares:527.40M
Float Shares:415.00M
Volume Ratio:1.20
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4410
EPS(LYR):-1.4410
ROE:-59.54%
ROA:-27.72%
PB:1.49
PE(LYR):-2.21

Loading ...

BUZZ-Applied Digital, WeRide shares fall after Nvidia dissolves stake

Reuters
·
Feb 19

Shares of Recursion Pharmaceuticals Down 6% After Nvidia Dissolves Share Stake in Co

THOMSON REUTERS
·
Feb 18

Recursion Pharmaceuticals Shares Plunge Over 13% Premarket Following Nvidia's Complete Divestment

Stock News
·
Feb 18

Recursion Pharmaceuticals Inc. published an update to their financial calendar

Reuters
·
Feb 18

Press Release: Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25

Dow Jones
·
Feb 18

Applied Digital, Recursion Pharmaceuticals Stocks Drop. Blame Nvidia. -- Barrons.com

Dow Jones
·
Feb 18

Premarket Movers | New York Times Jumps 3%; Synopsys up 4%; RXRX Slides 13%; Palo Alto Networks Plunges 8%; APLD Sinks 7%; SanDisk down 2%

Tiger Newspress
·
Feb 18

Synopsys Jumps over 2% While APLD Plunges 9%. Nvidia Reports Share Stake In Intel, Nokia, Synopsys; Dissolves In ARM, APLD

Reuters
·
Feb 18

Novo Holdings Dissolves Share Stake In Recursion Pharmaceuticals

Reuters
·
Feb 18

BRIEF-Recursion Reports Grant Of Inducement Awards As Permitted By The Nasdaq Listing Rules

Reuters
·
Feb 12

Recursion Pharmaceuticals Grants Inducement RSUs to 17 New Employees

Reuters
·
Feb 12

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

GlobeNewswire
·
Feb 12

11 Stocks That Have Cratered and Look Like Buys -- Barrons.com

Dow Jones
·
Feb 10

Nvidia Concept Stocks Rally. Applied Digital And CoreWeave Up 7%; Nebius Up 6%; Nvidia And Core Scientific Up 3%; WeRide Up 2%

Tiger Newspress
·
Feb 09

Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Its Steep Share Price Declines And DCF Outlook

Simply Wall St.
·
Feb 09

Recursion Pharmaceuticals Director Christopher Gibson Reports Sale of Common Shares

Reuters
·
Feb 07

Recursion’s REC-4881 Cancer Trial Terminated: Reading the Signals for RXRX Investors

TIPRANKS
·
Feb 07

The Genesis Mission Has a 270-Day Timeline – And You’re Already Late

InvestorPlace
·
Jan 27

Is Recursion (RXRX) Turning Nvidia-Backed AI Hype Into a Durable Drug Discovery Advantage?

Simply Wall St.
·
Jan 23

Director Christopher Gibson Sells Common Shares of Recursion Pharmaceuticals Inc

Reuters
·
Jan 23